83779
PEP is emergency anti-HIV medication for HIV-negative individuals with recent exposure. Get emergency PEP for HIV prevention at PULSE, 7 days a week.
Dr.Deyn Natthakhet Yaemim (Founding Director) 6 June 2016, last updated 24 August 2022
Key Points
|
Condom Break? Get PEP in Bangkok at PULSE Clinic! If you need emergency PEP after a condom failure, visit PULSE Clinic. We are open 7 days a week, including weekdays and weekends, for your convenience! If you have had a high-risk exposure to HIV in the last 72 hours, it's crucial to begin HIV PEP (Post-Exposure Prophylaxis) as soon as possible. For optimal effectiveness, start PEP within 24 hours after potential exposure.
The sooner you initiate PEP, the better your chances of preventing HIV infection. Decades of research and experience demonstrate that PEP can significantly reduce the risk of HIV transmission.
Factors that can increase the risk of HIV infection and you are a potential candidate for PEP due to:
If you cannot access HIV PEP (Post-Exposure Prophylaxis) within 72 hours, even if it's been 5-7 days since potential exposure, it's still essential to consult a healthcare professional about your options. You may be eligible for a 3-drug combination of antiretroviral medications to begin early treatment, which can help minimize damage to your immune system in case you have contracted HIV. Taking prompt action can be crucial for your health.
For more information about getting HIV treatment at PULSE Clinic, contact us at info.bkk@pulse-clinic.com or chat with us via one of the following platforms:
+66 65 237 1936 @PULSEClinic PulseClinic
After potential exposure to HIV, it takes a few days for the virus to establish itself in the body. Once established, HIV can remain for life. However, starting PEP (Post-Exposure Prophylaxis) promptly can be crucial. Anti-HIV medications in PEP prevent the existing virus from replicating, allowing it to die out before it can multiply.
These PEP drugs support the body's immune system in halting the replication of HIV within infected cells. As a result, the initially infected cells can die off naturally within a short time, preventing further HIV production.
PEP is not a ‘cure’ for HIV. While PEP may prevent HIV from entering cells in the body and stop someone from becoming infected, it isn’t 100% effective. However, there have been very few reports of HIV infection after using PEP.
Not if you act quickly! After exposure, HIV can enter the bloodstream but takes time to establish itself permanently in the body. If a person exposed to HIV seeks PEP (Post-Exposure Prophylaxis) within 72 hours, they have a strong chance of preventing the virus from becoming established.
Research indicates that taking PEP makes infection with HIV a lot less likely. But PEP doesn’t work every time. Some people who take it still end up with HIV afterwards. When people taking PEP have acquired HIV, it can fail because:
However, the sooner PEP treatment is begun after exposure to the virus, the more likely it is to work.
We use the latest gold standard PEP medicines with fewer side effects and better HIV prevention which will be taken for 28 days.
For adults: Tenofovir combined with either Tenofovir (TDF) and emtricitabine (FTC) as preferred backbone drugs and these are also the preferred drugs for treating HIV.
The recommended third drug, which is also recommended by WHO and CDC as a preferred drug for HIV treatment, will be chosen by your doctor.
There are some of our clients who do not understand when our doctors try to explain about HIV drug resistant. If you are unlucky and being exposed to such HIV, the classic PEP medications are not able to help you. That's why American CDC suggested on their PEP treatment guidelines that we should use a higher class of drugs that is less likely to be resisted by the HIV drug resistant type. These higher class medications are available at our clinics and they are costly. Much more expensive than the classic PEP medications generally used in low income countries. When our doctors prescribe this higher class PEP medications it is because they evaluate that your risk is very high and they are trying to keep the standard as high as American Center of Disease Control Guidelines for PEP treatment.
Your doctor may recommend treatment as prevention for potential gonorrhea, chlamydia, or syphilis following unprotected sex or a sexual incident. We suggest the PCR multiplex test, which detects 28 infection that cause STD, available at PULSE Clinic.
Trust PULSE CLINIC to take care of your health like other 45000 people from over 130 countries. We provide discreet professional service with high privacy. Here to help, not to judge.
The doctor will assess your risk of HIV exposure before initiating treatment. Expect questions about the circumstances surrounding your potential exposure, including the type of sexual or injecting activity involved and whether your partner may be HIV-positive.
Specific inquiries may include:
These questions help determine the most appropriate course of action for your health.
It is important to be honest and accurate in providing this information – We are there to help you, not to judge you.
The information you provide will help us evaluate the seriousness of your situation. It’s important to note that the risk of contracting HIV through oral sex is extremely low. PEP (Post-Exposure Prophylaxis) is generally not recommended after potential exposure to HIV via oral sex. The only exception is if receptive oral sex was performed by a partner known to be HIV-positive, particularly if the receptive partner has cuts or lesions, such as ulcers, in their mouth.
At PULSE CLINIC (in every branch throughout Asia), we have seen this more than 4,000 times before; you’re not the first and you won’t be the last. The doctor won’t judge; they will be very helpful and make you feel at ease. If you think you’re at risk and need PEP, contact us.
+66 65 237 1936 @PULSEClinic PulseClinic
Staying consistent with your PEP (Post-Exposure Prophylaxis) medication is crucial for effectiveness. Here are some tips to help you remember to take your PEP daily for the entire month:
It's essential to be cautious when taking other medications while on PEP. PEP can interact with prescription drugs, supplements, and vitamins, potentially altering their effectiveness. Additionally, using recreational drugs during PEP can be risky and may lead to severe side effects when combined with certain PEP medications. Always consult with your prescribing doctor or nurse about any other medications you are currently taking or considering.
Once you've finished your PEP course, schedule a follow-up appointment with your healthcare provider to get tested for HIV. Your doctor will evaluate your risk factors and may recommend starting PrEP (Pre-Exposure Prophylaxis) for ongoing protection. It’s also advisable to get tested again three months after completing PEP to confirm your status.
PULSE Clinics are open 7 days a week, ensuring you receive care even if you experience exposure or a sexual incident over the weekend. Book an appointment with us or walk into any of our branches for immediate assistance.
Activity | Risk-per-exposure |
---|---|
Vaginal sex, female-to-male, studies in high-income countries | 0.04% (1:2380) |
Vaginal sex, male-to-female, studies in high-income countries | 0.08% (1:1234) |
Vaginal sex, female-to-male, studies in low-income countries | 0.38% (1:263) |
Vaginal sex, male-to-female, studies in low-income countries | 0.30% (1:333) |
Vaginal sex, source partner is asymptomatic | 0.07% (1:1428) |
Vaginal sex, source partner has late-stage disease | 0.55% (1:180) |
Receptive anal sex amongst gay men, partner unknown status | 0.27% (1:370) |
Receptive anal sex amongst gay men, partner HIV positive | 0.82% (1:123) |
Receptive anal sex with condom, gay men, partner unknown status | 0.18% (1:555) |
Insertive anal sex, gay men, partner unknown status | 0.06% (1:1666) |
Insertive anal sex with condom, gay men, partner unknown status | 0.04% (1:2500) |
Receptive fellatio | Estimates range from 0.00% to 0.04% (1:2500) |
Mother-to-child, mother takes at least two weeks antiretroviral therapy | 0.8% (1:125) |
Mother-to-child, mother takes combination therapy, viral load below 50 | 0.1% (1:1000) |
Injecting drug use | Estimates range from 0.63% (1:158) to 2.4% (1:41) |
Needlestick injury, no other risk factors | 0.13% (1:769) |
Blood transfusion with contaminated blood | 92.5% (9:10) |
Sources: vaginal sex;1 anal sex;2 fellatio;3 2 mother-to-child;4 other activities.5
References
1. Boily MC et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9(2): 118-129, 2009
2. Vittinghoff E et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. American Journal of Epidemiology 150: 306-311, 1999
3. Del Romero J et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS 16(9): 1296-1297, 2002
4. Townsend C et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 22: 973-981, 2008
5. Baggaley RF et al. Risk of HIV-1 transmission for parenteral exposure and blood transfusion. AIDS 20: 805-812, 2006
With whatever you’re experiencing, you are not alone. PULSE Social Enterprise is here for any concerns and questions that you might have about your health.
From general wellness to mental well-being to sexual health, we will be sure to give you fast, reliable, and safe diagnosis, treatment, and consultation.
Trust PULSE CLINIC to take care of your health like other 45000 people from over 130 countries. We provide discreet professional service with high privacy. Here to help, not to judge.